MedPath

Pilot: Interactive Tool for Self management through Lifestyle Feedback (for COPD and Diabetes type 2 patients in primary care)

Completed
Conditions
COPD and diabetes type 2
pulmonary disease and sugar disease
10018424
10006436
Registration Number
NL-OMON37441
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Diagnosed with COPD or Diabetes type 2 treated in primary care.
Age below 70 and above 40.
Additional inclusion criteria for the diabetes group are a recent (no longer than a year ago) HbA1c concentration of more than 7% and a body mass index of more than 25kg/m2.
For the COPD group the following additional inclusion criteria apply: a clinical diagnosis of COPD according to the GOLD-criteria stage 2 and 3 (post bronchodilator FEV1/IVC <= 70% and FEV1 between 30 and 80% of the predicted value); at least six weeks respiratory stable and on a stable drug regimen.

Exclusion Criteria

Patients with complex coexisting medical conditions with a low survival rate, severe psychiatric illness or chronic disorders or diseases that seriously influence the ability to be physically active (e.g. amputation, paralysis, claudication intermittens) and those being primarily treated by a medical specialist, as well as patients with insufficient mastery of the Dutch language will be excluded.
Furthermore, patients who do not own a computer with internet connection at home and therefore can*t receive a mail will be excluded. Since the practice nurses select patients from the medical information system, they will decide which patients will be included.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcomes: technical performance, usability, acceptance and user<br /><br>satisfaction.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes: physical activity, goal attainment, quality of life and<br /><br>self-efficacy. </p><br>
© Copyright 2025. All Rights Reserved by MedPath